A new drug, daraxonrasib, has shown a significant breakthrough in treating advanced pancreatic cancer by doubling survival time and improving quality of life, with results from a 500-patient trial set to inform future regulatory submissions.
Stacked weekly counts; colour by lean. “n/a” covers government and iwi-Māori sources where lean isn't applicable.
How this topic has been named, week by week. A new alias winning out is usually a framing shift.
How the news corpus has covered this same topic over the last 12 weeks. 1 article from RNZ, Stuff, NZ Herald, ODT, 1News, Newsroom and The Spinoff. Click through to the press view for the full panel.
Up to 12 framings spread across orientations. Each framing is a short phrase the topic extractor generated to characterise the piece's stance — not a quote from the source. Click through to read the original.
Spotted something wrong on this page? Report a correction.